{
    "code": "10000789",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=10000789",
    "time": "2024-03-21 22:51:47",
    "許可證字號": "衛署菌疫輸字第000789號",
    "註銷狀態": "已註銷",
    "註銷日期": "110\/12\/17",
    "註銷理由": "自請註銷",
    "製造許可登錄編號": "",
    "有效日期": "113\/01\/06",
    "發證\/登錄日期": "93\/01\/06",
    "許可證\/登錄種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA01000078904",
    "中文品名": "珮格西施 注射劑180微公克\/0.5毫升",
    "英文品名": "PEGASYS PREFILLED SYRINGES 180MCG\/0.5ML",
    "適應症": "１、治療慢性B型肝炎：對於沒有肝硬化的病人以及有代償功能的肝硬化病人，珮格西施適合用來治療HBeAg陽性或HBeAg陰性，有病毒複製和肝臟發炎證據之慢性B型肝炎。\r\n２、治療慢性C型肝炎成人病患：珮格西施可單獨或合併其他治療C型肝炎藥物一起使用，適合用來治療沒有肝硬化的病人以及有代償功能的肝硬化病人之慢性C型肝炎。",
    "劑型": "270注射劑",
    "包裝": "注射針筒 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "PEGINTERFERON ALFA-2A",
    "限制項目": "02輸　入",
    "申請商名稱": "羅氏大藥廠股份有限公司",
    "申請商地址": "台北市信義區松仁路100號40樓、40樓之1、41樓之1",
    "主製造廠": [
        {
            "製造廠名稱": "F.HOFFMANN-LA ROCHE LTD.",
            "製造廠廠址": "WURMISWEG, CH-4303 KAISERAUGST, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "ROCHE DIAGNOSTICS GMBH",
            "製造廠廠址": "NONNENWALD 2, D-82377 PENZBERG, GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "原料藥製造廠"
        }
    ],
    "CCC號列": "30049020007 血液代用品與血漿代用品及基因重組製劑Substitutes of blood, substitutes of plasma and preparations  of gennetic recombinants",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0818000770",
            "成分名稱": "PEGINTERFERON ALFA-2A",
            "含量描述": "",
            "含量": "180.0000000000",
            "單位": "MCG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Pegasys PFS 180mcg_BSL_10110049_LAB-104-09-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000789&Seq=002&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Pegasys PFS 135 and 180_0319-PEG-01-108-04-18(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000789&Seq=073&Type=9"
        },
        {
            "title": "Pegasys PFS_中文仿單_CDS 18_0717-PEG-01-106-08-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000789&Seq=072&Type=9"
        },
        {
            "title": "Pegasys 180mcg ex KAU_000789-2-CTN-02-108-04-18(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000789&Seq=005&Type=8"
        },
        {
            "title": "Pegasys PFS 180mcg_BSL_10110049_CTN-104-09-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000789&Seq=004&Type=8"
        }
    ]
}